Special Issue "Allergic Disease: Integrated Management by The Pharmacist"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 November 2020).
Allergic diseases are common chronic diseases associated with significant morbidity, lower quality of life, reduced productivity, and high health care costs. Successful management of allergic diseases has the potential to decrease this burden by lowering the disproportionate costs of hospitalization and acute care for exacerbations and comorbidities.
Increased public awareness has improved the education of patients and healthcare professionals, implementation of treatment guidelines, and availability of safe and effective therapies. All have been combined to provide an effective response to the increase in the prevalence of allergic diseases. However, the number of persons with poorly controlled disease or with complications remains high.
Broadly, allergic diseases can be treated using a number of different therapies. For some allergy sufferers, a combination of therapies is required to address their symptoms. Policy considerations are also mounting as medications become increasingly available over the counter at the community pharmacy.
Pharmacists are an integral part in the supply and safety of the medications as well as sharing a growing responsibility in the administration of medications, the transition of care, and clinical decision making for these patients. Cost-effective disease management that considers all stakeholders is urgently required.
I invite you to submit a manuscript for this Special Issue “Allergic Disease: Integrated Management by the Pharmacist” in the journal Pharmacy. Pharmacy (ISSN 2226-4787) is an international scientific open access journal on pharmacy education and practice published quarterly online by MDPI.
The overall goal of this Special Issue is to provide the reader with a broad scope of allergy management strategies, discussing issues around embedding quality into pharmacy practice, and showcasing programs and proposals that are designed to improve allergy care.
We seek a full breadth of manuscripts addressing topics including, but not limited to: asthma, allergic rhinitis, food allergy, and atopic dermatitis. We invite you to contribute original research, systematic reviews, short reports, case studies, and commentaries.
As an example, you may wish to take a look at previous Special Issues: https://www.mdpi.com/journal/pharmacy/special_issues/contemporary_issues_pharmacy_education
Prof. Dr. Olga Lourenço
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Allergic asthma
- Allergic rhinitis
- Atopic eczema/dermatitis
- Food Allergy